Correlation Between Bliss GVS and American Mutual

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bliss GVS and American Mutual at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bliss GVS and American Mutual into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bliss GVS Pharma and American Mutual Fund, you can compare the effects of market volatilities on Bliss GVS and American Mutual and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bliss GVS with a short position of American Mutual. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bliss GVS and American Mutual.

Diversification Opportunities for Bliss GVS and American Mutual

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Bliss and American is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Bliss GVS Pharma and American Mutual Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on American Mutual and Bliss GVS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bliss GVS Pharma are associated (or correlated) with American Mutual. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of American Mutual has no effect on the direction of Bliss GVS i.e., Bliss GVS and American Mutual go up and down completely randomly.

Pair Corralation between Bliss GVS and American Mutual

Assuming the 90 days trading horizon Bliss GVS Pharma is expected to generate 3.79 times more return on investment than American Mutual. However, Bliss GVS is 3.79 times more volatile than American Mutual Fund. It trades about 0.21 of its potential returns per unit of risk. American Mutual Fund is currently generating about -0.16 per unit of risk. If you would invest  11,815  in Bliss GVS Pharma on February 3, 2024 and sell it today you would earn a total of  1,125  from holding Bliss GVS Pharma or generate 9.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy86.96%
ValuesDaily Returns

Bliss GVS Pharma  vs.  American Mutual Fund

 Performance 
       Timeline  
Bliss GVS Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bliss GVS Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Bliss GVS may actually be approaching a critical reversion point that can send shares even higher in June 2024.
American Mutual 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in American Mutual Fund are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, American Mutual is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Bliss GVS and American Mutual Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bliss GVS and American Mutual

The main advantage of trading using opposite Bliss GVS and American Mutual positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bliss GVS position performs unexpectedly, American Mutual can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in American Mutual will offset losses from the drop in American Mutual's long position.
The idea behind Bliss GVS Pharma and American Mutual Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals